Publication | Closed Access

Nuclear IL-33 regulates soluble ST2 receptor and IL-6 expression in primary human arterial endothelial cells and is decreased in idiopathic pulmonary arterial hypertension

InflammationPulmonary Arterial HypertensionPulmonary CirculationCardiovascular DiseaseLung InflammationPhysiologyImmunologyEndothelial DysfunctionPathologySoluble St2 ReceptorAutoimmunityVascular BiologyNuclear Il-33Public HealthMedicineIl-6 ExpressionCell SignalingPulmonary Vascular Disease